Ian Matthew Raugh

Ian Matthew Raugh

Auto-generated profile, based on publicly available information

Ian Matthew Raugh

McGill University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
IRIan M Raugh
Ian M Raugh
SJSydney H James
Sydney H James
CGCristina M Gonzalez
Cristina M Gonzalez
HCHannah C Chapman
Hannah C Chapman
ACAlex S. Cohen
Alex S. Cohen
GSGregory P Strauss
Gregory P Strauss
Negative symptoms and functional outcome have traditionally been assessed using clinical rating scales, which rely on retrospective self-reports and have several inherent limitations that impact validity. These issues may be addressed with more objective digital phenotyping measures. In the current study, we evaluated the psychometric properties of a novel “passive” digital phenotyping method: geolocation. Participants included outpatients with schizophrenia or schizoaffective disorder (SZ: n = 44), outpatients with bipolar disorder (BD: n =19), and demographically matched healthy controls (CN: n = 42) who completed 6 days of “active” digital phenotyping assessments (eg, surveys) while geolocation was recorded. Results indicated that SZ patients show less activity than CN and BD, particularly, in their travel from home. Geolocation variables demonstrated convergent validity by small to medium correlations with negative symptoms and functional outcome measured via clinical rating scales, as well as active digital phenotyping behavioral indices of avolition, asociality, and anhedonia. Discriminant validity was supported by low correlations with positive symptoms, depression, and anxiety. Reliability was supported by good internal consistency and moderate stability across days. These findings provide preliminary support for the reliability and validity of geolocation as an objective measure of negative symptoms and functional outcome. Geolocation offers enhanced precision and the ability to take a “big data” approach that facilitates sophisticated computational models. Near-continuous recordings and large numbers of samples may make geolocation a novel outcome measure for clinical trials due to enhanced power to detect treatment effects.

23 January 2021 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
ACAlex S. Cohen
Alex S. Cohen
ESElana Schwartz
Elana Schwartz
TLThanh P Le
Thanh P Le
TCTovah Cowan
Tovah Cowan
BKBrian Kirkpatrick
Brian Kirkpatrick
GSGregory P Strauss
Gregory P Strauss
Negative symptoms are a critical, but poorly understood, aspect of schizophrenia. Measurement of negative symptoms primarily relies on clinician ratings, an endeavor with established reliability and validity. There have been increasing attempts to digitally phenotype negative symptoms using objective biobehavioral technologies, eg, using computerized analysis of vocal, speech, facial, hand and other behaviors. Surprisingly, biobehavioral technologies and clinician ratings are only modestly inter-related, and findings from individual studies often do not replicate or are counterintuitive. In this article, we document and evaluate this lack of convergence in 4 case studies, in an archival dataset of 877 audio/video samples, and in the extant literature. We then explain this divergence in terms of “resolution”—a critical psychometric property in biomedical, engineering, and computational sciences defined as precision in distinguishing various aspects of a signal. We demonstrate how convergence between clinical ratings and biobehavioral data can be achieved by scaling data across various resolutions. Clinical ratings reflect an indispensable tool that integrates considerable information into actionable, yet “low resolution” ordinal ratings. This allows viewing of the “forest” of negative symptoms. Unfortunately, their resolution cannot be scaled or decomposed with sufficient precision to isolate the time, setting, and nature of negative symptoms for many purposes (ie, to see the “trees”). Biobehavioral measures afford precision for understanding when, where, and why negative symptoms emerge, though much work is needed to validate them. Digital phenotyping of negative symptoms can provide unprecedented opportunities for tracking, understanding, and treating them, but requires consideration of resolution.

1 June 2020 in Schizophrenia Research
Verified
Journal Article
Closed access
ACAlex S. Cohen
Alex S. Cohen
TCTovah Cowan
Tovah Cowan
TLThanh P. Le
Thanh P. Le
ESElana K. Schwartz
Elana K. Schwartz
BKBrian Kirkpatrick
Brian Kirkpatrick
GSGregory P. Strauss
Gregory P. Strauss

1 February 2020 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
KVKatherine Frost Visser
Katherine Frost Visser
HCHannah C. Chapman
Hannah C. Chapman
IRIvan Ruiz
Ivan Ruiz
IRIan M. Raugh
Ian M. Raugh
GSGregory P. Strauss
Gregory P. Strauss

1 April 2024 in Emotion
Verified
Journal Article
Closed access
IRIan M. Raugh
Ian M. Raugh
GSGregory P. Strauss
Gregory P. Strauss
Extensive research has been conducted regarding how people manage their emotions. Within this research, there has been growing attention toward the role of mindfulness in emotion regulation. While prior reviews have discussed mindfulness in the context of emotion regulation, they have not provided a thorough integration using the prevailing models of emotion regulation or mindfulness. The present review discusses the Extended Process Model of Emotion Regulation and Monitoring and Acceptance Theory of mindfulness in order to propose a novel integrated framework, the Dual-mode Model of Mindful Emotion Regulation (D-MER). This model proposes two "modes" of mindfulness: Implementation and facilitation. Implementation posits that mindfulness skills can be used as emotion regulation strategies through attentional deployment and cognitive change. Facilitation posits that mindfulness as a state or trait affects emotion generation and regulation through effects on cognitive processes and positive or negative valence systems. Further, the D-MER posits that mindfulness experience can improve the efficiency of mindfulness-based emotion regulation strategies (implementation) while effects of mindfulness on emotion regulation processes become increasingly trait-like and automatic over time (facilitation). Empirical and theoretical support for this model are discussed, specific hypotheses to guide further research are provided, and clinical implications are presented. Use of this model may identify mechanisms underlying the interaction between mindfulness and emotion regulation which can be used in ongoing affective and clinical research. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

1 March 2019 in Psychological Assessment
Verified
Journal Article
Open access
IRIan M. Raugh
Ian M. Raugh
HCHannah C. Chapman
Hannah C. Chapman
LBLisa A. Bartolomeo
Lisa A. Bartolomeo
CGCristina Gonzalez
Cristina Gonzalez
GSGregory P. Strauss
Gregory P. Strauss
Psychophysiological assessment is a core method used in psychopathology research that has led to important insights in relation to the etiology and maintenance of many disorders. However, laboratory psychophysiology has limited ecological validity. This limitation has resulted in the field moving toward ambulatory recordings of psychophysiology paired with ecological momentary assessment (EMA). This review uses the results of a comprehensive review of EMA psychophysiology studies to discuss applications, advantages, limitations, and future use of this methodology, including electrocardiography, blood pressure, electroencephalography, and more. Mobile psychophysiology has several advantages, including ecological validity, temporal precision, and concurrent evaluation of internally and externally generated contexts that influence physiological response. However, it is limited by the difficulty of conducting such studies and reduced experimental control. Future research using EMA psychophysiology should aim to record over longer periods, better integrate with everyday life, determine the utility of ecological momentary interventions based on psychophysiology, create guidelines for standardization, and aim to establish reliability and validity. EMA psychophysiology is a promising direction for the field and provides novel avenues for research and treatment of psychopathology, although methodological shortcomings must be addressed. (PsycINFO Database Record (c) 2019 APA, all rights reserved).